Evaluation of Hydroxyurea Plus L-arginine or Sildenafil to Treat Sickle Cell Anemia

NCT00056433 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

39

Enrollment

NIH

Sponsor class

Conditions

Sickle Cell Anemia

Interventions

DRUG: Hydroxyurea
DRUG: L-Arginine
DRUG: Sildenafil

Sponsor

National Institutes of Health Clinical Center (CC)